「clinical」の検索結果

Query ClinicalTrials.gov via API v2. Search trials by condition, drug, location, status, or phase. Retrieve trial details by NCT ID, export data, for clinical research and patient matching.

日本語の概要は準備中です。原文の説明を表示しています。

Write comprehensive clinical reports including case reports (CARE guidelines), diagnostic reports (radiology/pathology/lab), clinical trial reports (ICH-E3, SAE, CSR), and patient documentation (SOAP, H&P, discharge summaries). Full support with templates, regulatory compliance (HIPAA, FDA, ICH-GCP), and validation tools.

日本語の概要は準備中です。原文の説明を表示しています。

Search the ClinicalTrials.gov registry through its version 2 REST API for interventional and observational studies, their phases, enrolment, endpoints, sponsors, and posted results. Use this skill to survey who is developing what against an indication, date a competitor's programme, read primary and secondary outcome measures, find eligibility criteria, and distinguish a study that completed from one that was terminated or withdrawn. Also trigger on ClinicalTrials.gov, NCT number, trial registry, study phase, enrolment, primary outcome measure, recruiting status, trial sponsor, or competitive landscape.

日本語の概要は準備中です。原文の説明を表示しています。

Cross-reference ENCODE data with PubMed, bioRxiv, ClinicalTrials.gov, Open Targets, GTEx, ClinVar, GWAS Catalog, gnomAD, Ensembl, and other scientific databases. Use when the user wants to find publications, preprints, or clinical trials related to ENCODE experiments, chain ENCODE data with other scientific MCP servers, or build translational pipelines from genomic data to clinical application.

日本語の概要は準備中です。原文の説明を表示しています。

Use when a task needs the judgment of a Clinical Data Manager — designing a CRF/eCRF and edit-check specification, writing or triaging a data query, planning database lock readiness, reconciling external data (lab, ePRO, IRT) against the clinical database, or reviewing a data management plan for a trial.

日本語の概要は準備中です。原文の説明を表示しています。

Configure the Industries Enhanced Timeline in Health Cloud to display clinical events, custom object records, and activity history on a patient or member record. Trigger keywords: Enhanced Timeline, TimelineObjectDefinition, Industries Timeline, timeline categories, clinical event display, timeline configuration. NOT for building a custom timeline or patient-card LWC — use apex/health-cloud-lwc-components. NOT for the standard Task and Event activity timeline — use admin/activity-and-task-patterns.

日本語の概要は準備中です。原文の説明を表示しています。

Tests associations between categorical variables in clinical data using chi-square, Fisher's exact, Boschloo, Cochran-Mantel-Haenszel, and modern McNemar variants with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen). Use when analyzing categorical outcomes, paired binary endpoints, or testing treatment-outcome independence in confirmatory or exploratory clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Reads, validates, and prepares CDISC SDTM and ADaM clinical trial data for analysis. Covers SDTM domain joins (DM, AE, EX, VS, LB, DS), ADaM architecture (ADSL, BDS, OCCDS, ADTTE) with traceability, treatment-emergent AE conventions, baseline derivation, SUPPQUAL/NSV handling, Define-XML 2.1, and Pinnacle 21 / CORE validation. Use when working with clinical trial datasets in CDISC SDTM/ADaM format, preparing analysis-ready data, or validating for regulatory submission.

日本語の概要は準備中です。原文の説明を表示しています。

Performs logistic regression for clinical trial outcomes (binary, ordinal, multinomial) with marginal-vs-conditional estimand reporting per FDA 2023 covariate adjustment guidance, g-computation/standardisation for marginal effects, modified Poisson for RR, Brant test for proportional odds, Firth penalty for separation, and Hauck-Donner detection. Use when modeling binary or ordinal endpoints in confirmatory or exploratory clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Performs time-to-event analysis for clinical trials including Cox proportional hazards regression with PH diagnostics, restricted mean survival time (RMST) under non-PH, competing risks via Fine-Gray vs cause-specific Cox, weighted log-rank and MaxCombo for non-proportional hazards, recurrent events (Andersen-Gill, PWP, WLW), and interval-censored data. Use when analyzing time-to-event endpoints (OS, PFS, DOR, TTR, TTNT) in oncology or other clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Computes sample size and power for clinical trials including continuous, binary, and time-to-event endpoints; superiority, non-inferiority, and equivalence designs; FDA 2016 non-inferiority margin selection with M1/M2 framework; Schoenfeld 1981 and Lakatos 1988 for survival; Schuirmann TOST and 80-125% bioequivalence; minimum clinically important difference (MCID) vs δ distinction. Use when justifying trial size in protocol or SAP per CONSORT 2025 item 16a.

日本語の概要は準備中です。原文の説明を表示しています。

Expert-level clinical engineering covering medical equipment management, hospital technology systems, healthcare IT integration, safety standards, and health technology assessment.

日本語の概要は準備中です。原文の説明を表示しています。

医学证据等级排序与编排层 skill - evidence grading orchestrator. 当用户请求"证据等级 / GRADE / 证据排序 / 医学证据评估 / 系统评价排序 / 临床证据排序 / 证据金字塔 / 给 PMID 打分 / Practice Guideline 优先 / Cochrane 优先 / 反向证据交叉验证 / evidence grading / quality of evidence / evidence pyramid / GRADE assessment / Cochrane review ranking / clinical evidence ranking"时,**调用本 skill 进行医学证据自动分级,自动选择最佳信息源**。本 skill 是编排层(L2)·不直接打 NCBI/Europe PMC/ClinicalTrials API,而是编排 6 个底层原子 skill(pubmed-eutils / europepmc-search / clinical-trials-v2 / aact-bulk-trials / bioc-fulltext-fetch / pubtator-entity-search)的召回结果,按证据金字塔(指南 > Meta > RCT > Cohort > Case-Control > Case Report)做 GRADE A/B/C/D 自动评级,自动剔除 editorial/letter/comment。优先使用 BioMCP MCP server 做 fan-out(genomoncology/biomcp);无 BioMCP 时走自建 slow-path 兜底。跨平台无锁(Claude Code / Codex / Gemini CLI)。

日本語の概要は準備中です。原文の説明を表示しています。

EMR/EHR development patterns for healthcare applications. Clinical safety, encounter workflows, prescription generation, clinical decision support integration, and accessibility-first UI for medical data entry. Use when building EMR or EHR features such as encounter workflows, prescription generation, or clinical data entry UI.

日本語の概要は準備中です。原文の説明を表示しています。

当用户询问 ClinicalTrials.gov / 临床试验 / NCT / 试验注册 / 招募状态 / phase 1/2/3 / RCT lookup / sponsor 检索 / interventional trial / observational study / 主次要终点 / trial outcomes / 试验招募中 / recruiting status 时,通过 ClinicalTrials.gov API v2 实时检索官方注册数据。专注实时单次查询(≤1000 条/请求),典型场景: "某 NCT 试验最新状态"、"BTK 抑制剂 Phase 3 在招募试验"、"某试验已发布的主次要终点结果"。明确边界: 批量 >10k 试验 / 全库 SQL 历史分析 → aact-bulk-trials; 关联 PubMed 文献 → pubmed-eutils; RCT 自动 GRADE 评级 → medical-evidence-grading; 引用入报告附录 → evidence-appendix-sync。跨平台无锁(Claude Code / Codex / Cursor 通用)。

日本語の概要は準備中です。原文の説明を表示しています。

使用 AACT (Aggregate Analysis of ClinicalTrials.gov) PostgreSQL 数据库进行大批量临床试验历史分析与数据挖掘。触发场景包括：AACT 查询、临床试验批量分析、PostgreSQL 试验数据、全量 NCT 检索、试验数据挖掘、clinical trials data warehouse、疾病领域全景分析、设计相似试验匹配、跨年度试验趋势聚合。本 skill 通过 SQL 接口处理百万级试验记录，支持云端公共 PostgreSQL 服务（aact-db.ctti-clinicaltrials.org）和每日 dump 本地还原两种连接方式，自动检测并优先使用本地高性能模式。

日本語の概要は準備中です。原文の説明を表示しています。

Tests associations between categorical variables in clinical data using chi-square, Fisher's exact, Boschloo, Cochran-Mantel-Haenszel, and modern McNemar variants with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen). Use when analyzing categorical outcomes, paired binary endpoints, or testing treatment-outcome independence in confirmatory or exploratory clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Reads, validates, and prepares CDISC SDTM and ADaM clinical trial data for analysis. Covers SDTM domain joins (DM, AE, EX, VS, LB, DS), ADaM architecture (ADSL, BDS, OCCDS, ADTTE) with traceability, treatment-emergent AE conventions, baseline derivation, SUPPQUAL/NSV handling, Define-XML 2.1, and Pinnacle 21 / CORE validation. Use when working with clinical trial datasets in CDISC SDTM/ADaM format, preparing analysis-ready data, or validating for regulatory submission.

日本語の概要は準備中です。原文の説明を表示しています。

Performs logistic regression for clinical trial outcomes (binary, ordinal, multinomial) with marginal-vs-conditional estimand reporting per FDA 2023 covariate adjustment guidance, g-computation/standardisation for marginal effects, modified Poisson for RR, Brant test for proportional odds, Firth penalty for separation, and Hauck-Donner detection. Use when modeling binary or ordinal endpoints in confirmatory or exploratory clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Computes sample size and power for clinical trials including continuous, binary, and time-to-event endpoints; superiority, non-inferiority, and equivalence designs; FDA 2016 non-inferiority margin selection with M1/M2 framework; Schoenfeld 1981 and Lakatos 1988 for survival; Schuirmann TOST and 80-125% bioequivalence; minimum clinically important difference (MCID) vs δ distinction. Use when justifying trial size in protocol or SAP per CONSORT 2025 item 7.

日本語の概要は準備中です。原文の説明を表示しています。

Performs time-to-event analysis for clinical trials including Cox proportional hazards regression with PH diagnostics, restricted mean survival time (RMST) under non-PH, competing risks via Fine-Gray vs cause-specific Cox, weighted log-rank and MaxCombo for non-proportional hazards, recurrent events (Andersen-Gill, PWP, WLW), and interval-censored data. Use when analyzing time-to-event endpoints (OS, PFS, DOR, TTR, TTNT) in oncology or other clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

End-to-end clinical trial analysis workflow from CDISC SDTM/ADaM loading through ICH E9(R1) estimand-driven primary analysis to CONSORT 2025 regulatory-compliant reporting. Covers data preparation, FDA 2023 marginal vs conditional logistic regression, categorical tests with Boschloo, modern HTE/subgroup methods, missing-data sensitivity (MMRM, reference-based MI, Permutt tipping point), graphical multiplicity (Bretz-Maurer), survival analysis (Cox/RMST/competing risks) when applicable, and Table 1. Use when performing a complete analysis of clinical trial data.

日本語の概要は準備中です。原文の説明を表示しています。

Performs time-to-event analysis for clinical trials including Cox proportional hazards regression with PH diagnostics, restricted mean survival time (RMST) under non-PH, competing risks via Fine-Gray vs cause-specific Cox, weighted log-rank and MaxCombo for non-proportional hazards, recurrent events (Andersen-Gill, PWP, WLW), and interval-censored data. Use when analyzing time-to-event endpoints (OS, PFS, DOR, TTR, TTNT) in oncology or other clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Computes sample size and power for clinical trials including continuous, binary, and time-to-event endpoints; superiority, non-inferiority, and equivalence designs; FDA 2016 non-inferiority margin selection with M1/M2 framework; Schoenfeld 1981 and Lakatos 1988 for survival; Schuirmann TOST and 80-125% bioequivalence; minimum clinically important difference (MCID) vs δ distinction. Use when justifying trial size in protocol or SAP per CONSORT 2025 item 7.

日本語の概要は準備中です。原文の説明を表示しています。